We evaluated the effect of PH-797804 treatment on percentages of total CD4+ T cells and CM CD4+ T cells, which is considered an earlier prognostic marker in the infection, as CM CD4+ T cells decline earlier than total CD4+ T cells [68]. The gene discussed is CD4; the disease is infection.